Risk stratification after acute myocardial infarction: is it time to reassess? Implications from the INSPIRE trial.
Mahmarian
John J
JJ
Pratt
Craig M
CM
D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000401:mortality* / Q000628:therapy; D017063:Outcome Assessment, Health Care / Q000379:methods; D018579:Patient Selection; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D014481:United States / Q000453:epidemiology
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi